Dec 05, 2009 - 9:40 pm
$30,000-a-Month Cancer Drug
A newly approved chemotherapy drug will cost about $30,000 a month, a sign that the prices of cancer medicines are continuing to rise despite growing concern about health care costs.
Fred R. Conrad/The New York Times
Minh Uong/The New York Times
The price of Folotyn “seems way higher than I heard of before,” Robert L. Erwin, president of the Marti Nelson Cancer Foundation, a patient advocacy group. “I can’t imagine there not being a backlash against the pricing.”
Read the whole story here: